Para acceder a los documentos con el texto completo, por favor, siga el siguiente enlace: http://hdl.handle.net/2445/102456

Cost effectiveness of intermittent screening followed by treatment versus intermittent preventive treatment during pregnancy in West Africa: analysis and modelling of results from a non-inferiority trial
Fernandes, Silke; Sicuri, Elisa; Halimatou, Diawara; Akazili, James; Bojang, Kalifa; Chandramohan, Daniel; Coulibaly, Sheikh; Diawara, Sory Ibrahim; Kayentao, Kassoum; Kuile, Feiko ter; Magnussen, Pascal; Tagbor, Harry; Williams, John; Woukeu, Arouna; Cairns, Matthew; Greenwood, Brian; Hanson, Kara
Background: Emergence of high-grade sulfadoxine-pyrimethamine (SP) resistance in parts of Africa has led to growing concerns about the efficacy of intermittent preventive treatment of malaria during pregnancy (IPTp) with SP. The incremental cost-effectiveness of intermittent screening and treatment (ISTp) with artemether-lumefantrine (AL) as an alternative strategy to IPTp-SP was estimated followed by a simulation of the effects on cost-effectiveness of decreasing efficacy of IPTp-SP due to SP resistance. The analysis was based on results from a multi-centre, non-inferiority trial conducted in West Africa. Methods: A decision tree model was analysed from a health provider perspective. Model parameters for all trial countries with appropriate ranges and distributions were used in a probabilistic sensitivity analysis. Simulations were performed in hypothetical cohorts of 1000 pregnant women who received either ISTp-AL or IPTp-SP. In addition a cost-consequences analysis was conducted. Trial estimates were used to calculate disability-adjusted-life-years (DALYs) for low birth weight and severe/moderate anaemia (both shown to be non-inferior for ISTp-AL) and clinical malaria (inferior for ISTp-AL). Cost estimates were obtained from observational studies, health facility costings and public procurement databases. Results were calculated as incremental cost per DALY averted. Finally, the cost-effectiveness changes with decreasing SP efficacy were explored by simulation. Results: Relative to IPTp-SP, delivering ISTp-AL to 1000 pregnant women cost US$ 4966.25 more (95 % CI US$ 3703.53; 6376.83) and led to a small excess of 28.36 DALYs (95 % CI −75.78; 134.18), with LBW contributing 81.3 % of this difference. The incremental cost-effectiveness ratio was −175.12 (95 % CI −1166.29; 1267.71) US$/DALY averted. Simulations show that cost-effectiveness of ISTp-AL increases as the efficacy of IPTp-SP decreases, though the specific threshold at which ISTp-AL becomes cost-effective depends on assumptions about the contribution of bed nets to malaria control, bed net coverage and the willingness-to-pay threshold used. Conclusions: At SP efficacy levels currently observed in the trial settings it would not be cost-effective to switch from IPTp-SP to ISTp-AL, mainly due to the substantially higher costs of ISTp-AL and limited difference in outcomes. The modelling results indicate thresholds below which IPT-SP efficacy must fall for ISTp-AL to become a cost-effective option for the prevention of malaria in pregnancy.
Malària
Embaràs
Malaria
Pregnancy
cc by (c) Fernandes et al., 2016
http://creativecommons.org/licenses/by/3.0/es/
Artículo
info:eu-repo/semantics/publishedVersion
BioMed Central
         

Mostrar el registro completo del ítem

Documentos relacionados

Otros documentos del mismo autor/a

Tagbor, Harry; Cairns, Matthew; Bojang, Kalifa; Coulibaly, Sheikh; Kayentao, Kassoum; Williams, John; Abubakar, Ismaela; Akor, Francis; Mohammed, Khalifa; Bationo, Richard; Dabira, Edgar; Soulama, Alamissa; Djimdé, Moussa; Guirou, Etienne; Awine, Timothy; Quaye, Stephen; Njie, Fanta; Ordi i Majà, Jaume; Doumbo, Ogobara; Hodgson, Abraham; Oduro, Abraham; Meshnick, Steven; Taylor, Steve; Magnussen, Pascal; Ter Kuile, Feiko; Woukeu, Arouna; Milligan, Paul; Chandramohan, Daniel; Greenwood, Brian
Williams, John; Njie, Fanta; Cairns, Matthew; Bojang, Kalifa; Coulibaly, Sheikh; Kayentao, Kassoum; Abubakar, Ismaela; Akor, Francis; Mohammed, Khalifa; Bationo, Richard; Dabira, Edgar; Soulama, Alamissa; Djimdé, Moussa; Guirou, Etienne; Awine, Timothy; Quaye, Stephen L.; Ordi i Majà, Jaume; Doumbo, Ogobara; Hodgson, Abraham; Oduro, Abraham; Magnussen, Pascal; Ter Kuile, Feiko O.; Woukeu, Arouna; Milligan, Paul; Tagbor, Harry; Greenwood, Brian; Chandramohan, Daniel
Tagbor, Harry; Cairns, Matthew; Bojang, Kalifa; Coulibaly, Sheikh; Kayentao, Kassoum; Williams, John; Abubakar, Ismaela; Akor, Francis; Mohammed, Khalifa; Bationo, Richard; Dabira, Edgar; Soulama, Alamissa; Djimdé, Moussa; Guirou, Etienne; Awine, Timothy; Quaye, Stephen; Njie, Fanta; Ordi i Majà, Jaume; Doumbo, Ogobara; Hodgson, Abraham; Oduro, Abraham; Meshnick, Steven; Taylor, Steve; Magnussen, Pascal; Ter Kuile, Feiko; Woukeu, Arouna; Milligan, Paul; Chandramohan, Daniel; Greenwood, Brian
Williams, John; Njie, Fanta; Cairns, Matthew; Bojang, Kalifa; Coulibaly, Sheikh; Kayentao, Kassoum; Abubakar, Ismaela; Akor, Francis; Mohammed, Khalifa; Bationo, Richard; Dabira, Edgar; Soulama, Alamissa; Djimdé, Moussa; Guirou, Etienne; Awine, Timothy; Quaye, Stephen L.; Ordi i Majà, Jaume; Doumbo, Ogobara; Hodgson, Abraham; Oduro, Abraham; Magnussen, Pascal; Ter Kuile, Feiko O.; Woukeu, Arouna; Milligan, Paul; Tagbor, Harry; Greenwood, Brian; Chandramohan, Daniel
Fernandes, Silke; Sicuri, Elisa; Kayentao, Kassoum; Eijk, Anna Maria van; Hill, Jenny; Webster, Jayne; Were, Vincent; Akazili, James; Madanitsa, Mwayi; Ter Kuile, Feiko O.; Hanson, Kara